Merck (MRK) Tops Q1 EPS by 8c; updates guidance

Merck (NYSE: MRK) reported Q1 EPS of $2.22, $0.08 better than the analyst estimate of $2.14. Revenue for the quarter came in at $15.53 billion versus the consensus estimate of $15.33 billion.

GUIDANCE:

Merck sees FY2025 EPS of $8.82-$8.97, versus the consensus of $8.94. Merck sees FY2025 revenue of $64.1-65.6 billion, versus the consensus of $65.01 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• VNET Group (VNET) Misses Q2 EPS by 164c
• H.C. Wainwright Downgrades EyePoint Inc. (EYPT) to Neutral
• Barclays Starts Centrus Energy Corp. (LEU) at Equalweight